Safety and Antitumor Activity of Anti-PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer.
暂无分享，去创建一个
K. Yamaguchi | T. Honjo | N. Matsumura | T. Baba | M. Minami | S. Morita | I. Konishi | M. Yokode | T. Murayama | S. Chikuma | M. Mandai | J. Hamanishi | A. Kawaguchi | Akira Shimizu | M. Kanai | T. Ikeda | Y. Mori | S. Matsumoto | Y. Hosoe | Akihiko Ueda | K. Abiko